SCHEMBL23309697

SCHEMBL23309697

Cc1ccccc1NC(=O)c1cc(F)nc(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.56
▸ KDM4C Q9H3R0 1/20 0.56
▸ HPGD P15428 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MAPT P10636 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ MAOB P27338 1/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ POLB P06746 2/20 0.49
▸ KMT2A Q03164 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ F12 P00748 1/20 0.46
▸ PKM P14618 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309594 0.84 POLB (0.50) ALDH1A1KDM4EMAPK1MAOBNPC1
SCHEMBL23309603 0.83 CYP1A2 (0.56) HPGDCYP1A2CYP2C19NPC1RAB9A
SCHEMBL23309709 0.80 EPHB3 (0.50) HTTALDH1A1HSD17B10KDM4ELMNA
SCHEMBL23309490 0.80 GAA (0.51) HTTHPGDALDH1A1HSD17B10KDM4E
SCHEMBL23309595 0.78 EPHB3 (0.47) HTTHPGDALDH1A1KDM4ELMNA
SCHEMBL23309483 0.78 CYP1A2 (0.52) HTTALDH1A1HSD17B10MAPTCYP1A2
SCHEMBL22819946 0.77 HPGD (0.68) HTTKDM4CHPGDALDH1A1HSD17B10
SCHEMBL23309730 0.77 KMT2A (0.47) HTTALDH1A1KDM4ELMNAMAPK1
SCHEMBL23309621 0.77 RAB9A (0.50) HTTHPGDALDH1A1HSD17B10KDM4E
SCHEMBL23309614 0.77 LCK (0.45) ALDH1A1LMNAMAPTPKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL HTT 2558/4885KDM4C 1826/4885HPGD 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback